The CIBMTR score predicts survival of AML patients undergoing allogeneic transplantation with active disease after a myeloablative or reduced intensity conditioning: a retrospective analysis of the Gruppo Italiano Trapianto Di Midollo Osseo.

ABSTRACT:

SUBMITTER: Todisco E 

PROVIDER: S-EPMC3806246 | biostudies-literature | 2013 Oct

REPOSITORIES: biostudies-literature